Harpoon Therapeutics, Inc. Free Cash Flow 2019-2023 | HARP
Harpoon Therapeutics, Inc. free cash flow from 2019 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Harpoon Therapeutics, Inc. Annual Free Cash Flow |
| 2022 |
-89.53 |
| 2021 |
-122.25 |
| 2020 |
-9.30 |
| 2019 |
-6.41 |
| 2018 |
-27.79 |
| 2017 |
-0.56 |
| 2016 |
-11.35 |
| Harpoon Therapeutics, Inc. Quarterly Free Cash Flow |
| 2023-09-30 |
-49.80 |
| 2023-06-30 |
-33.18 |
| 2023-03-31 |
-19.29 |
| 2022-12-31 |
-89.53 |
| 2022-09-30 |
-71.11 |
| 2022-06-30 |
-46.89 |
| 2022-03-31 |
-24.64 |
| 2021-12-31 |
-122.25 |
| 2021-09-30 |
-105.37 |
| 2021-06-30 |
-84.69 |
| 2021-03-31 |
-18.12 |
| 2020-12-31 |
-9.30 |
| 2020-09-30 |
5.93 |
| 2020-06-30 |
19.88 |
| 2020-03-31 |
-17.52 |
| 2019-12-31 |
-6.41 |
| 2019-09-30 |
-39.76 |
| 2019-06-30 |
-26.77 |
| 2019-03-31 |
-12.50 |
| 2018-09-30 |
-21.19 |
| 2018-06-30 |
-13.90 |
